An‐Chi Tsai

436 total citations
12 papers, 384 citations indexed

About

An‐Chi Tsai is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, An‐Chi Tsai has authored 12 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in An‐Chi Tsai's work include Cancer Mechanisms and Therapy (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). An‐Chi Tsai is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). An‐Chi Tsai collaborates with scholars based in Taiwan, United States and Czechia. An‐Chi Tsai's co-authors include Shiow‐Lin Pan, Che‐Ming Teng, Ya-Ling Chang, Hui-Lung Sun, Mei-Chuan Chen, Chin-Yu Lai, Chieh-Yu Peng, Jing‐Ping Liou, Chien-Chih Chen and Kuo‐Hsiung Lee and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Clinical Cancer Research.

In The Last Decade

An‐Chi Tsai

12 papers receiving 378 citations

Peers

Countries citing papers authored by An‐Chi Tsai

Since Specialization

Citations

This map shows the geographic impact of An‐Chi Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An‐Chi Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An‐Chi Tsai more than expected).

Fields of papers citing papers by An‐Chi Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An‐Chi Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An‐Chi Tsai. The network helps show where An‐Chi Tsai may publish in the future.

Co-authorship network of co-authors of An‐Chi Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of An‐Chi Tsai. A scholar is included among the top collaborators of An‐Chi Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An‐Chi Tsai. An‐Chi Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Synergistic Interaction between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer Cells In Vitro and In Vivo 2014 ·Clinical Cancer Research ·(unknown), Mei-Chuan Chen, (unknown), An‐Chi Tsai, Ching-Shih Chen, Jing‐Ping Liou, Shiow‐Lin Pan, Che‐Ming Teng	40
2	Azaindolylsulfonamides, with a More Selective Inhibitory Effect on Histone Deacetylase 6 Activity, Exhibit Antitumor Activity in Colorectal Cancer HCT116 Cells 2014 ·Journal of Medicinal Chemistry ·Hsueh‐Yun Lee, An‐Chi Tsai, Mei-Chuan Chen, (unknown), (unknown), Ching‐Chuan Kuo, Shiow‐Lin Pan, Yi-Min Liu, (unknown), Teng-Kuang Yeh, (unknown), Chi-Yen Chang, Jang‐Yang Chang, Jing‐Ping Liou	68
3	Activated PAR-2 Regulates Pancreatic Cancer Progression through ILK/HIF-α–Induced TGF-α Expression and MEK/VEGF-A–Mediated Angiogenesis 2013 ·American Journal Of Pathology ·(unknown), Shiow‐Lin Pan, Chin-Yu Lai, An‐Chi Tsai, Che‐Ming Teng	40
4	In vitro and in vivo anti‐tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non‐small‐cell lung cancer cells 2013 ·British Journal of Pharmacology ·An‐Chi Tsai, (unknown), (unknown), Jing‐Ping Liou, Che‐Ming Teng, (unknown), Shiow‐Lin Pan	8
5	Aciculatin Induces p53-Dependent Apoptosis via MDM2 Depletion in Human Cancer Cells In Vitro and In Vivo 2012 ·PLoS ONE ·Chin-Yu Lai, An‐Chi Tsai, Mei-Chuan Chen, (unknown), Hui-Lung Sun, Ya-Ling Chang, Chien-Chih Chen, Che‐Ming Teng, Shiow‐Lin Pan	40
6	Dehydrocostuslactone Suppresses Angiogenesis In Vitro and In Vivo through Inhibition of Akt/GSK-3β and mTOR Signaling Pathways 2012 ·PLoS ONE ·(unknown), An‐Chi Tsai, Chieh-Yu Peng, Ya-Ling Chang, Kuo‐Hsiung Lee, Che‐Ming Teng, Shiow‐Lin Pan	43
7	The inhibition of angiogenesis and tumor growth by denbinobin is associated with the blocking of insulin-like growth factor-1 receptor signaling 2010 ·The Journal of Nutritional Biochemistry ·An‐Chi Tsai, Shiow‐Lin Pan, Chin-Yu Lai, (unknown), Chien-Chih Chen, Chien-Chang Shen, Che‐Ming Teng	12
8	The Indazole Derivative YD-3 Specifically Inhibits Thrombin-Induced Angiogenesis In Vitro and In Vivo 2010 ·Shock ·Chieh-Yu Peng, Shiow‐Lin Pan, (unknown), An‐Chi Tsai, Jih‐Hwa Guh, Ya-Ling Chang, Sheng-Chu Kuo, Fang-Yu Lee, Che‐Ming Teng	5
9	EPOX Inhibits Angiogenesis by Degradation of Mcl-1 through ERK Inactivation 2009 ·Clinical Cancer Research ·Hui-Lung Sun, An‐Chi Tsai, Shiow‐Lin Pan, Qingqing Ding, Hirohito Yamaguchi, Chun-Nan Lin, Mien‐Chie Hung, Che‐Ming Teng	20
10	Moscatilin, a bibenzyl derivative from the India orchid Dendrobrium loddigesii, suppresses tumor angiogenesis and growth in vitro and in vivo 2009 ·Cancer Letters ·An‐Chi Tsai, Shiow‐Lin Pan, (unknown), Jih‐Hwa Guh, Shih‐Wei Wang, Hui-Lung Sun, Yi-Nan Liu, Chien-Chih Chen, Chien-Chang Shen, Ya-Ling Chang, Che‐Ming Teng	57
11	CHM-1, a New Vascular Targeting Agent, Induces Apoptosis of Human Umbilical Vein Endothelial Cells via p53-mediated Death Receptor 5 Up-regulation 2009 ·Journal of Biological Chemistry ·An‐Chi Tsai, Shiow‐Lin Pan, Hui-Lung Sun, (unknown), Chieh-Yu Peng, Shih‐Wei Wang, Ya-Ling Chang, Sheng-Chu Kuo, Kuo‐Hsiung Lee, Che‐Ming Teng	25
12	CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression 2007 ·Cancer Letters ·Shih‐Wei Wang, Shiow‐Lin Pan, Chieh-Yu Peng, (unknown), An‐Chi Tsai, Ya-Ling Chang, Jih‐Hwa Guh, Sheng-Chu Kuo, Kuo‐Hsiung Lee, Che‐Ming Teng	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact